DHS Secretary Calls on Congress to Close FDA Green-List Loopholes Over Fentanyl
DHS Secretary Markwayne Mullin urged Congress to eliminate gaps in the FDA’s green-list that allow fentanyl precursors into the United States, citing recent interdiction successes and tribal jurisdiction challenges.
During a policy event, DHS Secretary Markwayne Mullin pressed Congress to close loopholes in the FDA’s green-list, which he said enable fentanyl and its precursors to bypass controls. He praised Homeland Security Investigations for recent interdiction gains but warned that pressure on the southern border has shifted the problem inland, exemplified by the largest fentanyl laboratory seizure on a tribal reservation this year.
Mullin highlighted jurisdictional conflicts between DHS, HHS, and tribal authorities that create opportunities for organized crime. He also noted that synthetic opioids are arriving from India and China, underscoring the need for tighter regulatory coordination. The secretary urged legislative measures to give agencies clearer authority to shut down these pathways.
Why it matters
Closing the FDA green-list loopholes could curb the flow of fentanyl precursors and reduce opioid abuse in the U.S.
In this story
